SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-21-000882
Filing Date
2021-04-07
Accepted
2021-04-07 16:07:01
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-3 a2243144zf-3.htm F-3 419780
2 EX-5.1 a2243144zex-5_1.htm EX-5.1 49640
3 EX-23.1 a2243144zex-23_1.htm EX-23.1 5774
4 EX-23.2 a2243144zex-23_2.htm EX-23.2 4384
5 G347127.JPG g347127.jpg GRAPHIC 14439
6 G857029.JPG g857029.jpg GRAPHIC 43825
7 G184968.JPG g184968.jpg GRAPHIC 35944
8 G532074.JPG g532074.jpg GRAPHIC 58156
9 G523531.JPG g523531.jpg GRAPHIC 54681
10 G115552KGI001.GIF g115552kgi001.gif GRAPHIC 804
11 G115552KGI002.GIF g115552kgi002.gif GRAPHIC 621
12 G115552MEI001.JPG g115552mei001.jpg GRAPHIC 2607
  Complete submission text file 0001047469-21-000882.txt   772344
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000
Type: F-3 | Act: 33 | File No.: 333-255089 | Film No.: 21812182
SIC: 2834 Pharmaceutical Preparations